Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer-Reference-Cited by-同舟云学术

Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer

Published:2016-06-06 Issue:28 Volume:7 Page:44062-44075
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Huber Michaela C.¹,Falkenberg Natalie¹,Hauck Stefanie M.²,Priller Markus²,Braselmann Herbert³,Feuchtinger Annette¹⁴,Walch Axel¹⁴,Schmitt Manfred⁵,Aubele Michaela¹

Affiliation:

1. Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany

2. Research Unit of Protein Science, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany

3. Research Unit of Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany

4. Research Unit of Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg 85764, Germany

5. Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität München, München 81675, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential;International Journal of Molecular Sciences;2023-01-20

2. Circulating Cysteine Rich Protein 61 (Cyr61, CCN1) in Chinese Adults: Distribution and Reference Intervals;Clinical Laboratory;2021

3. The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role;Thrombosis and Haemostasis;2018-11-12

4. Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5;Oncotarget;2017-08-24

5. Clinical relevance of Cyr61 expression in patients with hormone-dependent breast cancer;Oncology Letters;2017-06-16